VRAX Virax Biolabs Group Limited

NASDAQ
$3.19

Virax Biolabs Group Limited (VRAX) SEC Filings

Everything VRAX has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

1 filings
Date Form Filing
6-K INVESTOR_PRESENTATION

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.